Irish Cancer Society downplays the serious and often fatal side-effects of conventional treatments.
“First, do no harm” Hippocrates
It then goes on to discuss side effects like Fatigue, Hair Loss, Skin and Nail Changes etc. but does not even mention the fact that conventional treatments can (a) cause Cachexia (weakness and wasting of the body due to severe chronic illness and linked to chemotherapy) or (b) the fact that they are known carcinogens that often cause secondary cancers.
Both of these side-effects result in numerous deaths and yet, incredibly, they are not even mentioned.
Possible complications for any surgical procedure include:
- Complications related to anesthesia, including pneumonia, blood clots and, rarely, death
- Infection at the incision site, which may worsen scarring and require additional surgery
Source: Mayo Clinic
Atrial fibrillation after surgery increases risk of heart attacks and strokes during the first 12 months after surgery.
Source: Science Daily / University of Toronto
Surgery can make cancers grow faster
Life Extension Magazine in America reported as early as 1985 that cancer surgery increased the risk of metastases. By 2001 the British Journal of Cancer contained an article stating that removal of the primary tumour may result in sudden acceleration of the metastatic process. By 2009 in the Annals of Surgery, researchers reported that cancer surgery itself can create an environment in the body that greatly lessens the obstacles to metastases. This corroborates observations that relatively soon after surgery, metastatic lesions quickly emerge that were not necessarily evident prior to the surgical procedure – Bill Fallon, Life Extension magazine.
This study refers to a small international group that “suggests tumor growth commonly includes extended periods of quasi-stable dormancy. Furthermore, surgery to remove the primary tumor often awakens distant dormant micrometastases. Accordingly, over half of all relapses in breast cancer are accelerated in this manner”.
Metastasis – The Biggest Danger of Biopsies. Puncturing the tumor can result in the release in micrscopic quantities of cancer cells into the surrounding lymphatic system of blood vessels. This can allow the cancer cells to move to distant organs and grow.
Prostate Cancer. Prostate cancer biopsies require needle aspirations of up to 30 different samples, which means thirty different punctures, and thirty opportunities for cancer to spread. Additional complications include the prevalence of antibiotic resistant sepsis, a potentially lethal blood infection, in patients undergoing prostate biopsies.
Breast Cancer. Breast cancer biopsies have been associated with complications such as pain, swelling, bleeding and drainage from the biopsy site. This can lead to infections. False positives are also prevalent from biopsies, resulting in unnecessary treatments. Dr. Vincent Gammill from the Center for the Study of Natural Oncology in Solana Beach, California, reported the case of a woman who had successfully battled breast cancer since 1994 with natural methods. She was convinced to do a needle biopsy by an oncologist, and now she has new tumors growing at each of the puncture sites. Dr. Gamill states that he rarely sees distant metastasis until after a biopsy, but following that it grows rapidly, especially in the bones.
This study says that by inserting a needle or a knife into a tumor, there is a jeopardy of dislodging a loose tumor cell into either the circulation or into the tissue fluid. Tumor cells are easier to dislodge due to lower cell-to-cell adhesion. This theory with the possibility of seeding of tumor cells is supported by several case studies that have shown that after diagnostic biopsy of a tumor, many patients developed cancer at multiple sites and showed the presence of circulating cancer cells in the blood stream on examination.
This is an outrageous lie.
According to Accuray (manufacturer of radiation therapy equipment):
Important Safety Statement:
Side effects can be severe, however, leading to pain, alterations in normal body functions (for example, urinary or salivary function), deterioration of quality of life, permanent injury and even death.
According to the website of the National Cancer Institute:
Radiation side effects
- Cell damage that leads to new cancer.
- Hair loss
- Mouth and throat changes
- Nausea and vomiting
- Problems around sexuality and fertility in men
- Problems around sexuality and fertility in women
- Skin changes
- Urination changes
This is from Leukemia and Lymphoma Society
Radiation therapy to the chest can cause:
- Lung damage (scarring, inflammation, breathing difficulties)
- Heart damage (scarring, inflammation, coronary heart disease)
- Osteosarcoma (bone cancer)
- Breast cancer
- Thyroid cancer
- Hypothyroidism or hyperthyroidism
This Study: Intensity-modulated radiation therapy, protons, and the risk of second cancers says the downside to Intensity-modulated radiation therapy is the potential to increase the number of radiation-induced second cancers…
…Intensity-modulated radiation therapy may double the incidence of solid cancers in long-term survivors.
Source: International Journal of Radiation Oncology
Radiation therapy was recognized as a potential cause of cancer many years ago…
Most kinds of leukemia, including acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), and acute lymphoblastic leukemia (ALL) can be caused by past radiation exposure.
(Source: American Cancer Society)
With respect to stomach, pancreatic, and colorectal cancers, the authors of this study found that the greatest risk of secondary cancers following treatment for Hodgkin’s Lymphoma was associated with previous radiation treatment below the diaphragm or procarbazine-containing chemotherapy. Procarbazine was also implicated in the increased risk of non-Hodgkin’s lymphoma.
This study concluded that radiotherapy for prostate cancer was associated with higher risks of developing second malignancies of the bladder, colon, and rectum compared with patients unexposed to radiotherapy
This study, looking at the risk of secondary malignancies after radiation therapy for breast cancer, found that there was an increased risk in specific sites for patients treated with radiation therapy. This risk was most evident in young patients and who had longer latency* periods.
*The time that passes between being exposed to radiation and having symptoms.
Chemotherapy and other drugsThis downplaying of serious adverse effects is extremely misleading.
This 2016 study carried out by Public Health England and Cancer Research UK looked at more than 29,112 patients with breast cancer and 15,545 patients with lung cancer who underwent chemotherapy in 2014. Of those treated, 1,974 died within 30 days.
Some of these patients died of disease progression or from other causes.
Read the full article in Lancet Oncology
This 2017 study, which looked at chemotherapy side-effects, concluded: In this cohort, the majority of participants experienced multiple side effects and for 60% of participants at least one side effect was serious.
This study published in 2017 says chemotherapy
“ may increase cancer cell dissemination and induce a more aggressive tumor phenotype with increased metastasis.”
Chemo can cause cancer to return
This study states:
Interestingly, rates of tumor cell repopulation have been shown to accelerate in the intervals between successive courses of treatment, and solid tumors commonly show initial responses followed by rapid regrowth and subsequent resistance to further chemotherapy. Our results indicate that damage responses in benign cells comprising the tumor microenvironment may directly contribute to enhanced tumor growth kinetics.
“Most cancer patients in this country die of chemotherapy. Chemotherapy does not eliminate breast, colon, or lung cancers. This fact has been documented for over a decade, yet doctors still use chemotherapy for these tumors.”
— Allen Levin, MD, UCSF — The Healing of Cancer
A look at just 2 chemo (or other) drugs commonly given to cancer patients. The side-effects listed below are only a sample of the full range of side-effects observed. Please see individual manufacturers site for further details.
Manufacturer: Roche Group
Condition or Diseases treated: Metastatic Colorectal Cancer
Information supplied by: Genentech USA
Possible serious side effects
Most serious side effects (not common, but sometimes fatal):
A hole that develops in your stomach or intestine. Symptoms include pain in your abdomen, nausea, vomiting, constipation, or fever
Wounds that don’t heal
A cut made during surgery can be slow to heal or may not fully heal.
This includes vomiting or coughing up blood; bleeding in the stomach, brain, or spinal cord; nosebleeds; and vaginal bleeding.
What are the other possible serious side effects?
% = Percentage of patients who had this side effect in clinical studies across different cancers
Severe high blood pressure 18%
Blood pressure that severely spikes or shows signs of affecting the brain.
Kidney problems 7%
These may be caused by too much protein in the urine and can sometimes be fatal
Infusion reactions 3%
Infusion reactions include high blood pressure or severe high blood pressure that
may lead to stroke
decreased oxygen in red blood cells
a serious allergic reaction
Severe stroke or heart problems 2.6%
These may include blood clots, mini-stroke, heart attack, and chest pain.
These can sometimes be fatal
Abnormal passage in the body 2%
This type of passage—known as a fistula—is an irregular connection from one part of the body to another and can sometimes be fatal
Nervous system and vision problems 0.5%
Signs include headache, seizure, high blood pressure, sluggishness, confusion, and blindness
Condition or Diseases treated: Breast cancer
Information source Medicines.ie
Pregnancy. There have been a small number of reports of spontaneous abortions, birth defects and foetal deaths after women have taken Nolvadex, although no causal relationship has been establishd.
An increased incidence of endometrial cancer and uterine sarcoma (mostly malignant mixed Mullerian tumors) has been reported in association with Nolvadex treatment.
A number of second primary tumours, occurring at sites other than the endometrium and the opposite breast, have been reported in clinical trials, following the treatment of breast cancer patients with tamoxifen.
Breast cancer patients initially treated with tamoxifen have a twofold increased risk of uterine corpus cancer, with particularly high risks seen for rare tumors of the mixed mullerian type.
Source: Second Cancers – Landmark Studies
“All of these effects are normal so try not to worry.”
Irish Cancer Society.